{"transactions":[{"id":4622995,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-18T22:57:24.000Z","date":"2026-09-16","kind":"grant","planned":false,"acquired":true,"shares":10531,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Reflects an annual award of stock options to purchase Common Shares granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of stock options is scheduled to vest and become exercisable 100% on September 16, 2027, subject generally to the reporting person's service as a director through such date."}],"balance_after":10531,"derivative":{"exercise_price":39.57,"expiration_date":"2036-09-15","underlying":"Common Shares","underlying_shares":10531},"source":{"system":"sec-edgar","filing":"0001349297-26-000010","document":"wk-form4_1789772242.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000134929726000010/wk-form4_1789772242.xml","form_type":"4"}},{"id":4622994,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-09-18T22:57:24.000Z","date":"2026-09-16","kind":"grant","planned":false,"acquired":true,"shares":5054,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an annual award of restricted stock units with respect to Common Shares (\"RSUs\") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of RSUs is scheduled to vest 100% on September 16, 2027, subject generally to the reporting person's service as a director through such date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects an annual award of restricted stock units with respect to Common Shares (\"RSUs\") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of RSUs is scheduled to vest 100% on September 16, 2027, subject generally to the reporting person's service as a director through such date."}],"balance_after":41162,"source":{"system":"sec-edgar","filing":"0001349297-26-000010","document":"wk-form4_1789772242.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000134929726000010/wk-form4_1789772242.xml","form_type":"4"}},{"id":4622114,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-09-17T22:42:16.000Z","date":"2026-09-15","kind":"sale","planned":true,"acquired":false,"shares":400,"price":40.45,"value":16180.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.28 to $40.51, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on March 30, 2026."}],"balance_after":36108,"source":{"system":"sec-edgar","filing":"0001349297-26-000008","document":"wk-form4_1789684933.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000134929726000008/wk-form4_1789684933.xml","form_type":"4"}},{"id":4622113,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-09-17T22:42:16.000Z","date":"2026-09-15","kind":"sale","planned":true,"acquired":false,"shares":4712,"price":39.68,"value":186972.16,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.26 to $40.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on March 30, 2026."}],"balance_after":36508,"source":{"system":"sec-edgar","filing":"0001349297-26-000008","document":"wk-form4_1789684933.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000134929726000008/wk-form4_1789684933.xml","form_type":"4"}},{"id":4617447,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-09-14T22:29:07.000Z","date":"2026-09-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1743,"price":40.94,"value":71358.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the \"net settlement\" by the Issuer of Common Shares previously granted to the reporting person pursuant to the Issuer's Non-Employee Director Compensation Plan in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such Common Shares."}],"balance_after":41220,"source":{"system":"sec-edgar","filing":"0001349297-26-000006","document":"wk-form4_1789424944.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000134929726000006/wk-form4_1789424944.xml","form_type":"4"}},{"id":4615523,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-11T01:00:26.000Z","date":"2026-09-08","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Reflects an award of stock options to purchase Common Shares that is fully vested."}],"balance_after":18578,"derivative":{"exercise_price":8.8,"expiration_date":"2033-04-19","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001140361-26-036246","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036126036246/form4.xml","form_type":"4"}},{"id":4615522,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true}}],"security":"Common Shares","published_at":"2026-09-11T01:00:26.000Z","date":"2026-09-08","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":39.9,"value":798000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.90 to $40.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on March 30, 2026."}],"balance_after":42963,"source":{"system":"sec-edgar","filing":"0001140361-26-036246","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036126036246/form4.xml","form_type":"4"}},{"id":4615521,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true}}],"security":"Common Shares","published_at":"2026-09-11T01:00:26.000Z","date":"2026-09-08","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":8.8,"value":176000.0,"ownership":{"direct":true},"balance_after":62963,"source":{"system":"sec-edgar","filing":"0001140361-26-036246","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036126036246/form4.xml","form_type":"4"}},{"id":717906,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-02T23:03:57.000Z","date":"2026-06-30","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Award of stock options to purchase Common Shares that is fully vested."}],"balance_after":38578,"derivative":{"exercise_price":8.8,"expiration_date":"2033-04-19","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001349297-26-000004","document":"wk-form4_1783033435.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000134929726000004/wk-form4_1783033435.xml","form_type":"4"}},{"id":717905,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-07-02T23:03:57.000Z","date":"2026-06-30","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":34.9,"value":349000.0,"ownership":{"direct":true},"balance_after":42963,"source":{"system":"sec-edgar","filing":"0001349297-26-000004","document":"wk-form4_1783033435.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000134929726000004/wk-form4_1783033435.xml","form_type":"4"}},{"id":717904,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-07-02T23:03:57.000Z","date":"2026-06-30","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":8.8,"value":88000.0,"ownership":{"direct":true},"balance_after":52963,"source":{"system":"sec-edgar","filing":"0001349297-26-000004","document":"wk-form4_1783033435.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000134929726000004/wk-form4_1783033435.xml","form_type":"4"}},{"id":761059,"issuer":{"id":2563,"kind":"organization","name":"TENET HEALTHCARE CORP","symbol":"THC"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"2026 May Restricted Stock Units","published_at":"2026-05-29T00:00:02.000Z","date":"2026-05-27","kind":"grant","planned":false,"acquired":true,"shares":1188,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. These restricted stock units vest on the first anniversary of the date of grant. The reporting person may elect to receive up to 37% of these restricted stock units in cash in lieu of shares."}],"balance_after":1188,"derivative":{"exercise_date":"2027-05-27","expiration_date":"2027-05-27","underlying":"Common Stock","underlying_shares":1188},"source":{"system":"sec-edgar","filing":"0001193125-26-245804","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/70318/000119312526245804/ownership.xml","form_type":"4"}},{"id":765081,"issuer":{"id":2563,"kind":"organization","name":"TENET HEALTHCARE CORP","symbol":"THC"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"2025 May Restricted Stock Units","published_at":"2026-05-27T00:00:10.000Z","date":"2026-05-22","kind":"exercise","planned":false,"acquired":false,"shares":1333,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock.  The reporting person settled 37% of his restricted stock units for cash and 63% for shares of THC common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock.  The reporting person settled 37% of his restricted stock units for cash and 63% for shares of THC common stock."}],"balance_after":0,"derivative":{"exercise_date":"2026-05-22","expiration_date":"2026-05-22","underlying":"Common Stock","underlying_shares":1333},"source":{"system":"sec-edgar","filing":"0001193125-26-239938","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/70318/000119312526239938/ownership.xml","form_type":"4"}},{"id":765080,"issuer":{"id":2563,"kind":"organization","name":"TENET HEALTHCARE CORP","symbol":"THC"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-27T00:00:10.000Z","date":"2026-05-22","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":493,"price":173.78,"value":85673.54,"ownership":{"direct":true},"balance_after":17087,"source":{"system":"sec-edgar","filing":"0001193125-26-239938","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/70318/000119312526239938/ownership.xml","form_type":"4"}},{"id":765079,"issuer":{"id":2563,"kind":"organization","name":"TENET HEALTHCARE CORP","symbol":"THC"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-27T00:00:10.000Z","date":"2026-05-22","kind":"exercise","planned":false,"acquired":true,"shares":1333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock.  The reporting person settled 37% of his restricted stock units for cash and 63% for shares of THC common stock."}],"balance_after":17580,"source":{"system":"sec-edgar","filing":"0001193125-26-239938","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/70318/000119312526239938/ownership.xml","form_type":"4"}},{"id":825245,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-31T01:01:19.000Z","date":"2026-03-26","kind":"exercise","planned":false,"acquired":false,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award of stock options to purchase Common Shares that is fully vested."}],"balance_after":48578,"derivative":{"exercise_price":8.8,"expiration_date":"2033-04-19","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001140361-26-012063","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036126012063/form4.xml","form_type":"4"}},{"id":825244,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true}}],"security":"Common Shares","published_at":"2026-03-31T01:01:19.000Z","date":"2026-03-26","kind":"sale","planned":false,"acquired":false,"shares":70000,"price":27.45,"value":1921500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.32 to $27.80, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range."}],"balance_after":42963,"source":{"system":"sec-edgar","filing":"0001140361-26-012063","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036126012063/form4.xml","form_type":"4"}},{"id":825243,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true}}],"security":"Common Shares","published_at":"2026-03-31T01:01:19.000Z","date":"2026-03-26","kind":"exercise","planned":false,"acquired":true,"shares":70000,"price":8.8,"value":616000.0,"ownership":{"direct":true},"balance_after":112963,"source":{"system":"sec-edgar","filing":"0001140361-26-012063","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036126012063/form4.xml","form_type":"4"}},{"id":1041530,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-13T01:00:24.000Z","date":"2025-09-10","kind":"grant","planned":false,"acquired":true,"shares":33726,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Reflects an annual award of stock options to purchase Common Shares granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of stock options is scheduled to vest and become exercisable 100% on September 10, 2026, subject generally to the reporting person's continuous service through such date."}],"balance_after":33726,"derivative":{"exercise_price":13.77,"expiration_date":"2035-09-09","underlying":"Common Shares","underlying_shares":33726},"source":{"system":"sec-edgar","filing":"0001140361-25-034932","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036125034932/form4.xml","form_type":"4"}},{"id":1041529,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true}}],"security":"Common Shares","published_at":"2025-09-13T01:00:24.000Z","date":"2025-09-10","kind":"other","planned":false,"acquired":false,"shares":937,"price":13.77,"value":12902.49,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the \"net settlement\" by the Issuer of Common Shares previously granted to the reporting person pursuant to the Issuer's Non-Employee Director Compensation Plan in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such Common Shares."}],"balance_after":42963,"source":{"system":"sec-edgar","filing":"0001140361-25-034932","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036125034932/form4.xml","form_type":"4"}},{"id":1041528,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true}}],"security":"Common Shares","published_at":"2025-09-13T01:00:24.000Z","date":"2025-09-10","kind":"grant","planned":false,"acquired":true,"shares":14524,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an annual award of restricted stock units with respect to Common Shares (\"RSUs\") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy.  The award of RSUs is scheduled to vest 100% on September 10, 2026, subject generally to the reporting person's continuous service through such date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects an annual award of restricted stock units with respect to Common Shares (\"RSUs\") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy.  The award of RSUs is scheduled to vest 100% on September 10, 2026, subject generally to the reporting person's continuous service through such date."}],"balance_after":43900,"source":{"system":"sec-edgar","filing":"0001140361-25-034932","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036125034932/form4.xml","form_type":"4"}},{"id":1134583,"issuer":{"id":2563,"kind":"organization","name":"TENET HEALTHCARE CORP","symbol":"THC"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-05-28T00:00:09.000Z","date":"2025-05-23","kind":"exercise","planned":false,"acquired":false,"shares":1551,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock.  The reporting person settled 37% of her restricted stock units for cash and 63% for shares of THC common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock.  The reporting person settled 37% of her restricted stock units for cash and 63% for shares of THC common stock."}],"balance_after":0,"derivative":{"exercise_date":"2025-05-23","expiration_date":"2025-05-23","underlying":"Common Stock","underlying_shares":1551},"source":{"system":"sec-edgar","filing":"0000950170-25-078016","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/70318/000095017025078016/ownership.xml","form_type":"4"}},{"id":1134582,"issuer":{"id":2563,"kind":"organization","name":"TENET HEALTHCARE CORP","symbol":"THC"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-05-28T00:00:09.000Z","date":"2025-05-22","kind":"grant","planned":false,"acquired":true,"shares":1333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. These restricted stock units vest on the first anniversary of the date of grant. The reporting person may elect to receive up to 37% of these restricted stock units in cash in lieu of shares."}],"balance_after":1333,"derivative":{"exercise_date":"2026-05-22","expiration_date":"2026-05-22","underlying":"Common Stock","underlying_shares":1333},"source":{"system":"sec-edgar","filing":"0000950170-25-078016","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/70318/000095017025078016/ownership.xml","form_type":"4"}},{"id":1134581,"issuer":{"id":2563,"kind":"organization","name":"TENET HEALTHCARE CORP","symbol":"THC"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-28T00:00:09.000Z","date":"2025-05-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":573,"price":161.33,"value":92442.09,"ownership":{"direct":true},"balance_after":16247,"source":{"system":"sec-edgar","filing":"0000950170-25-078016","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/70318/000095017025078016/ownership.xml","form_type":"4"}},{"id":1134580,"issuer":{"id":2563,"kind":"organization","name":"TENET HEALTHCARE CORP","symbol":"THC"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-28T00:00:09.000Z","date":"2025-05-23","kind":"exercise","planned":false,"acquired":true,"shares":1551,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock.  The reporting person settled 37% of her restricted stock units for cash and 63% for shares of THC common stock."}],"balance_after":16820,"source":{"system":"sec-edgar","filing":"0000950170-25-078016","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/70318/000095017025078016/ownership.xml","form_type":"4"}},{"id":1406618,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true}}],"security":"Common Shares","published_at":"2024-09-17T01:00:47.000Z","date":"2024-09-12","kind":"other","planned":false,"acquired":false,"shares":894,"price":12.12,"value":10835.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the \"net settlement\" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs."}],"balance_after":29376,"source":{"system":"sec-edgar","filing":"0001140361-24-041230","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036124041230/form4.xml","form_type":"4"}},{"id":1408589,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-13T01:00:20.000Z","date":"2024-09-10","kind":"grant","planned":false,"acquired":true,"shares":27894,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Reflects an annual award of stock options to purchase Common Shares granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of stock options is scheduled to vest and become exercisable 100% on September 10, 2025, subject generally to the reporting person's continuous service through such date."}],"balance_after":27894,"derivative":{"exercise_price":12.19,"expiration_date":"2034-09-09","underlying":"Common Shares","underlying_shares":27894},"source":{"system":"sec-edgar","filing":"0001140361-24-040986","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036124040986/form4.xml","form_type":"4"}},{"id":1408588,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true}}],"security":"Common Shares","published_at":"2024-09-13T01:00:20.000Z","date":"2024-09-10","kind":"grant","planned":false,"acquired":true,"shares":16406,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an annual award of restricted stock units with respect to Common Shares (\"RSUs\") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy.  The award of RSUs is scheduled to vest 100% on September 10, 2025, subject generally to the reporting person's continuous service through such date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects an annual award of restricted stock units with respect to Common Shares (\"RSUs\") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy.  The award of RSUs is scheduled to vest 100% on September 10, 2025, subject generally to the reporting person's continuous service through such date."}],"balance_after":30270,"source":{"system":"sec-edgar","filing":"0001140361-24-040986","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036124040986/form4.xml","form_type":"4"}},{"id":1438278,"issuer":{"id":2563,"kind":"organization","name":"TENET HEALTHCARE CORP","symbol":"THC"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-09T00:00:04.000Z","date":"2024-08-06","kind":"sale","planned":false,"acquired":false,"shares":20000,"price":146.34,"value":2926800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $146.16 to $146.68. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":15269,"source":{"system":"sec-edgar","filing":"0000950170-24-094286","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/70318/000095017024094286/ownership.xml","form_type":"4"}},{"id":1501319,"issuer":{"id":2563,"kind":"organization","name":"TENET HEALTHCARE CORP","symbol":"THC"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-29T00:00:09.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":1551,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. These restricted stock units vest on the first anniversary of the date of grant. The reporting person may elect to receive up to 37% of these restricted stock units in cash in lieu of shares."}],"balance_after":1551,"derivative":{"exercise_date":"2025-05-23","expiration_date":"2025-05-23","underlying":"Common Stock","underlying_shares":1551},"source":{"system":"sec-edgar","filing":"0000950170-24-065554","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/70318/000095017024065554/ownership.xml","form_type":"4"}},{"id":1534759,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true}}],"security":"Common Shares","published_at":"2024-04-27T01:01:11.000Z","date":"2024-04-24","kind":"tax_withholding","planned":true,"acquired":false,"shares":83,"price":10.9,"value":904.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the \"net settlement\" by the Issuer of Common Shares previously granted to the reporting person pursuant to the Issuer's Non-Employee Director Compensation Plan in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such Common Shares."}],"balance_after":13864,"source":{"system":"sec-edgar","filing":"0001140361-24-022618","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036124022618/form4.xml","form_type":"4"}},{"id":1534758,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true}}],"security":"Common Shares","published_at":"2024-04-27T01:01:11.000Z","date":"2024-04-24","kind":"grant","planned":true,"acquired":true,"shares":1261,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date."}],"balance_after":13947,"source":{"system":"sec-edgar","filing":"0001140361-24-022618","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036124022618/form4.xml","form_type":"4"}},{"id":1672997,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true}}],"security":"Common Shares","published_at":"2024-01-24T02:00:34.000Z","date":"2024-01-19","kind":"grant","planned":false,"acquired":true,"shares":1328,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an award of Common Shares received pursuant to the Company's Non-Employee Director Compensation Plan that was fully vested as of the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects an award of Common Shares received pursuant to the Company's Non-Employee Director Compensation Plan that was fully vested as of the grant date."}],"balance_after":12686,"source":{"system":"sec-edgar","filing":"0001140361-24-003553","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036124003553/form4.xml","form_type":"4"}},{"id":1758119,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true}}],"security":"Common Shares","published_at":"2023-10-19T01:30:18.000Z","date":"2023-10-16","kind":"grant","planned":false,"acquired":true,"shares":1269,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an award of Common Shares received pursuant to the Company's Non-Employee Director Compensation Plan that was fully vested as of the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects an award of Common Shares received pursuant to the Company's Non-Employee Director Compensation Plan that was fully vested as of the grant date."}],"balance_after":11358,"source":{"system":"sec-edgar","filing":"0001140361-23-048774","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123048774/form4.xml","form_type":"4"}},{"id":1781032,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-15T01:31:13.000Z","date":"2023-09-12","kind":"grant","planned":false,"acquired":true,"shares":13334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Reflects an annual award of stock options to purchase Common Shares granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of stock options is scheduled to vest and become exercisable 100% on September 12, 2024, subject generally to the reporting person's continuous service through such date."}],"balance_after":13334,"derivative":{"exercise_price":11.22,"expiration_date":"2033-09-11","underlying":"Common Shares","underlying_shares":13334},"source":{"system":"sec-edgar","filing":"0001140361-23-044044","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123044044/form4.xml","form_type":"4"}},{"id":1781031,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true}}],"security":"Common Shares","published_at":"2023-09-15T01:31:13.000Z","date":"2023-09-12","kind":"grant","planned":false,"acquired":true,"shares":8937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an annual award of restricted stock units with respect to Common Shares (\"RSUs\") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy.  The award of RSUs is scheduled to vest 100% on September 12, 2024, subject generally to the reporting person's continuous service through such date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects an annual award of restricted stock units with respect to Common Shares (\"RSUs\") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy.  The award of RSUs is scheduled to vest 100% on September 12, 2024, subject generally to the reporting person's continuous service through such date."}],"balance_after":10089,"source":{"system":"sec-edgar","filing":"0001140361-23-044044","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123044044/form4.xml","form_type":"4"}},{"id":1833821,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true}}],"security":"Common Shares","published_at":"2023-07-07T01:30:20.000Z","date":"2023-07-03","kind":"grant","planned":false,"acquired":true,"shares":1152,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an award of Common Shares received pursuant to the Company's Non-Employee Director Compensation Plan that was fully vested as of the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects an award of Common Shares received pursuant to the Company's Non-Employee Director Compensation Plan that was fully vested as of the grant date."}],"balance_after":1152,"source":{"system":"sec-edgar","filing":"0001140361-23-033546","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123033546/form4.xml","form_type":"4"}},{"id":1846007,"issuer":{"id":2563,"kind":"organization","name":"TENET HEALTHCARE CORP","symbol":"THC"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-23T23:08:20.000Z","date":"2023-05-26","kind":"grant","planned":false,"acquired":true,"shares":3682,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected)."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected)."},{"field":"shares","element":"transactionShares","label":"F2","text":"This amendment is being filed to correct the amount of restricted stock units granted on May 26, 2023."}],"balance_after":35269,"source":{"system":"sec-edgar","filing":"0001209191-23-039535","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/70318/000120919123039535/doc4a.xml","form_type":"4/A","original_submission_date":"2023-05-30"}},{"id":1875717,"issuer":{"id":2563,"kind":"organization","name":"TENET HEALTHCARE CORP","symbol":"THC"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-30T21:14:54.000Z","date":"2023-05-26","kind":"grant","planned":false,"acquired":true,"shares":2846,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units granted under the Company's Stock Incentive Plan.  Each restricted stock unit is the economic equivalent of one share of the Company's common stock.  All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected)."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted under the Company's Stock Incentive Plan.  Each restricted stock unit is the economic equivalent of one share of the Company's common stock.  All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected)."}],"balance_after":34433,"source":{"system":"sec-edgar","filing":"0001209191-23-032941","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/70318/000120919123032941/doc4.xml","form_type":"4"}},{"id":1914884,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-25T01:28:24.000Z","date":"2023-04-20","kind":"grant","planned":false,"acquired":true,"shares":118578,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Award of stock options to purchase Common Shares with a vesting commencement date of March 13, 2023. These options vest and become exercisable (i) 1/3 on the first anniversary of the vesting commencement date and (ii) in twenty-four (24) successive equal monthly installments measured from the first anniversary of the vesting commencement date, subject to the reporting person's continuous service through the applicable vesting date."}],"balance_after":118578,"derivative":{"exercise_price":8.8,"expiration_date":"2033-04-19","underlying":"Common Shares","underlying_shares":118578},"source":{"system":"sec-edgar","filing":"0001140361-23-019995","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123019995/form4.xml","form_type":"4"}},{"id":2275580,"issuer":{"id":2563,"kind":"organization","name":"TENET HEALTHCARE CORP","symbol":"THC"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-11T20:45:02.000Z","date":"2022-05-09","kind":"grant","acquired":true,"shares":3836,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units granted under the Company's Stock Incentive Plan.  Each restricted stock unit is the economic equivalent of one share of the Company's common stock.  All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected)."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted under the Company's Stock Incentive Plan.  Each restricted stock unit is the economic equivalent of one share of the Company's common stock.  All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected)."}],"balance_after":31587,"source":{"system":"sec-edgar","filing":"0001209191-22-028333","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/70318/000120919122028333/doc4.xml","form_type":"4"}},{"id":2564525,"issuer":{"id":2563,"kind":"organization","name":"TENET HEALTHCARE CORP","symbol":"THC"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-20T21:36:00.000Z","date":"2021-09-16","kind":"sale","acquired":false,"shares":6077,"price":72.7,"value":441797.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold in an open market broker transaction."}],"balance_after":27751,"source":{"system":"sec-edgar","filing":"0001209191-21-056915","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/70318/000120919121056915/doc4.xml","form_type":"4"}},{"id":2696345,"issuer":{"id":2563,"kind":"organization","name":"TENET HEALTHCARE CORP","symbol":"THC"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-26T20:44:05.000Z","date":"2021-05-24","kind":"sale","acquired":false,"shares":6153,"price":63.57,"value":391146.21,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold in open market broker transactions."}],"balance_after":33828,"source":{"system":"sec-edgar","filing":"0001209191-21-035948","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/70318/000120919121035948/doc4.xml","form_type":"4"}},{"id":2720186,"issuer":{"id":2563,"kind":"organization","name":"TENET HEALTHCARE CORP","symbol":"THC"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-11T21:47:53.000Z","date":"2021-05-07","kind":"grant","acquired":true,"shares":3960,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units granted under the Company's Stock Incentive Plan.  Each restricted stock unit is the economic equivalent of one share of the Company's common stock.  All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected)."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted under the Company's Stock Incentive Plan.  Each restricted stock unit is the economic equivalent of one share of the Company's common stock.  All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected)."}],"balance_after":39981,"source":{"system":"sec-edgar","filing":"0001209191-21-031803","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/70318/000120919121031803/doc4.xml","form_type":"4"}},{"id":3128477,"issuer":{"id":2563,"kind":"organization","name":"TENET HEALTHCARE CORP","symbol":"THC"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-02T23:12:20.000Z","date":"2020-05-29","kind":"grant","acquired":true,"shares":11139,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units granted under the Company's Stock Incentive Plan.  Each restricted stock unit is the economic equivalent of one share of the Company's common stock.  All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected)."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted under the Company's Stock Incentive Plan.  Each restricted stock unit is the economic equivalent of one share of the Company's common stock.  All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected)."}],"balance_after":36021,"source":{"system":"sec-edgar","filing":"0001209191-20-033748","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/70318/000120919120033748/doc4.xml","form_type":"4"}},{"id":3203854,"issuer":{"id":2563,"kind":"organization","name":"TENET HEALTHCARE CORP","symbol":"THC"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-18T22:15:17.000Z","date":"2020-03-17","kind":"purchase","acquired":true,"shares":6153,"price":13.02,"value":80112.06,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were purchased in open market broker transactions."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price is the weighted average purchase price of the aggregate number of shares that were purchased by the reporting person. These shares were purchased in multiple transactions at prices ranging from $13.00 to $13.04. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price."}],"balance_after":24882,"source":{"system":"sec-edgar","filing":"0001209191-20-020079","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/70318/000120919120020079/doc4.xml","form_type":"4"}},{"id":3537397,"issuer":{"id":2563,"kind":"organization","name":"TENET HEALTHCARE CORP","symbol":"THC"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-07T21:56:13.000Z","date":"2019-05-03","kind":"grant","acquired":true,"shares":10817,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units granted under the Company's Stock Incentive Plan.  Each restricted stock unit is the economic equivalent of one share of the Company's common stock.  All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected)."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted under the Company's Stock Incentive Plan.  Each restricted stock unit is the economic equivalent of one share of the Company's common stock.  All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected)."}],"balance_after":18729,"source":{"system":"sec-edgar","filing":"0001209191-19-028054","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/70318/000120919119028054/doc4.xml","form_type":"4"}},{"id":3890408,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (Right to Buy)","published_at":"2018-06-18T22:58:45.000Z","date":"2018-06-14","kind":"grant","acquired":true,"shares":3453,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in equal quarterly installments over a one-year period, through and including June 14, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were awarded to the director per such director's election to receive annual cash compensation in the form of stock options."}],"balance_after":13453,"derivative":{"exercise_price":19.59,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":3453},"source":{"system":"sec-edgar","filing":"0000899243-18-017077","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1349297/000089924318017077/doc4.xml","form_type":"4"}},{"id":3890407,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (Right to Buy)","published_at":"2018-06-18T22:58:45.000Z","date":"2018-06-14","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in equal quarterly installments over a one-year period, through and including June 14, 2019."}],"balance_after":10000,"derivative":{"exercise_price":19.59,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-18-017077","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1349297/000089924318017077/doc4.xml","form_type":"4"}},{"id":3909950,"issuer":{"id":2563,"kind":"organization","name":"TENET HEALTHCARE CORP","symbol":"THC"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-04T22:46:25.000Z","date":"2018-05-31","kind":"grant","acquired":true,"shares":7912,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units granted to new non-employee director upon appointment to Board of Directors pursuant to the Company's Stock Incentive Plan.  Each restricted stock unit is the economic equivalent of one share of the Company's common stock.  All of these restricted stock units vested immediately on the grant date.  1,835 restricted stock units will be settled in shares of common stock upon termination of service from the Board and 6,077 will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected)."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to new non-employee director upon appointment to Board of Directors pursuant to the Company's Stock Incentive Plan.  Each restricted stock unit is the economic equivalent of one share of the Company's common stock.  All of these restricted stock units vested immediately on the grant date.  1,835 restricted stock units will be settled in shares of common stock upon termination of service from the Board and 6,077 will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected)."}],"balance_after":7912,"source":{"system":"sec-edgar","filing":"0001209191-18-035345","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/70318/000120919118035345/doc4.xml","form_type":"4"}},{"id":4277122,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":32848,"kind":"person","name":"Fitzgerald Meghan","position":1,"cik":"0001349297","reported_name":"Fitzgerald Meghan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2017-06-19T11:27:30.000Z","date":"2017-06-15","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in equal quarterly installments over a one-year period, through and including June 15, 2018."}],"balance_after":10000,"derivative":{"exercise_price":13.29,"expiration_date":"2027-06-14","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-17-040705","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1349297/000120919117040705/doc4.xml","form_type":"4"}}]}